Patents by Inventor Holly Hogrefe

Holly Hogrefe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240294886
    Abstract: Mutant polymerases are provided that have improved ability to incorporate modified nucleotides, including 3?—OH unblocked reversible terminators. The mutant polymerases may be used in a variety of applications, such as for polynucleotide sequencing, primer extension reactions, and template-independent enzymatic oligonucleotide synthesis.
    Type: Application
    Filed: May 1, 2024
    Publication date: September 5, 2024
    Inventors: Michelle Cayouette, Jeffrey Fox, Connie Hansen, Holly Hogrefe, Weidong Wu
  • Patent number: 12006519
    Abstract: Mutant polymerases are provided that have improved ability to incorporate modified nucleotides, including 3?-OH unblocked reversible terminators. The mutant polymerases may be used in a variety of applications, such as for polynucleotide sequencing, primer extension reactions, and template-independent enzymatic oligonucleotide synthesis.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: June 11, 2024
    Assignee: Agilent Technologies, Inc.
    Inventors: Michelle Cayouette, Jeffrey Fox, Connie Hansen, Holly Hogrefe, Weidong Wu
  • Publication number: 20240018490
    Abstract: Mutant polymerases are provided that have improved ability to incorporate modified nucleotides, including 3?-OH unblocked reversible terminators. The mutant polymerases may be used in a variety of applications, such as for polynucleotide sequencing, primer extension reactions, and template-independent enzymatic oligonucleotide synthesis.
    Type: Application
    Filed: September 11, 2023
    Publication date: January 18, 2024
    Inventors: Michelle Cayouette, Jeffrey Fox, Connie Hansen, Holly Hogrefe, Weidong Wu
  • Patent number: 11773380
    Abstract: Mutant polymerases are provided that have improved ability to incorporate modified nucleotides, including 3?-OH unblocked reversible terminators. The mutant polymerases may be used in a variety of applications, such as for polynucleotide sequencing, primer extension reactions, and template-independent enzymatic oligonucleotide synthesis.
    Type: Grant
    Filed: August 24, 2022
    Date of Patent: October 3, 2023
    Assignee: Agilent Technologies, Inc.
    Inventors: Michelle Cayouette, Jeffrey Fox, Connie Hansen, Holly Hogrefe, Weidong Wu
  • Patent number: 11718847
    Abstract: Methods and compositions are provided for amplifying a pool of oligonucleotides, such as dual guide oligonucleotide constructs comprising sequences encoding a first guide RNA segment and a sequence encoding a second guide RNA segment. An amplification mixture is formed comprising the pool of oligonucleotides, an amplification enzyme, deoxyribonucleotide triphosphates, and primers. The amplification mixture is thermocycled a sufficient number of times and under conditions to produce a library of oligonucleotide constructs. The present methods and compositions provide dual guide libraries, including libraries that are essentially free of scrambled library members.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: August 8, 2023
    Assignee: Agilent Technologies, Inc.
    Inventors: Jeffrey Carl Braman, Peter James Sheffield, Holly Hogrefe
  • Publication number: 20230126241
    Abstract: Methods and compositions are described for multi-stage primer extension reactions such as multiplex polymerase chain reactions (PCR) and reverse transcriptase PCR. Primer extension stages are performed in a closed vessel without opening the vessel between stages. The multi-stage primer extension methods and compositions utilize earlier stage primers in an earlier stage and later stage primers in a later stage, wherein the later stage primers are blocked from extension during the earlier stage. The blocked primers of the present technology comprise photocleavable blocking groups and are substantially inactive until the blocking group is cleaved by exposure to ultraviolet light. The blocked primers can be activated by ultraviolet light without opening the vessel.
    Type: Application
    Filed: February 3, 2021
    Publication date: April 27, 2023
    Inventors: Jinchun Wang, Jurgen Del Favero, Weidong Wu, Holly Hogrefe
  • Publication number: 20200071690
    Abstract: Methods and compositions are provided for amplifying a pool of oligonucleotides, such as dual guide oligonucleotide constructs comprising sequences encoding a first guide RNA segment and a sequence encoding a second guide RNA segment. An amplification mixture is formed comprising the pool of oligonucleotides, an amplification enzyme, deoxyribonucleotide triphosphates, and primers. The amplification mixture is thermocycled a sufficient number of times and under conditions to produce a library of oligonucleotide constructs. The present methods and compositions provide dual guide libraries, including libraries that are essentially free of scrambled library members.
    Type: Application
    Filed: August 29, 2018
    Publication date: March 5, 2020
    Inventors: Jeffrey Carl Braman, Peter James Sheffield, Holly Hogrefe
  • Patent number: 10308979
    Abstract: This disclosure provides a method comprising: a) clamping the top and bottom strands of a double stranded DNA molecule to produce a duplex in which the top and bottom strands are linked; b) denaturing the duplex to produce a denatured product; and c) renaturing the denatured product in the presence of a labeled oligonucleotide that is complementary to a sequence of nucleotides in the double stranded DNA molecule, thereby producing a D-loop-containing product. Kits for performing the method and products made by the method are also provided.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: June 4, 2019
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Brian Jon Peter, Robert A. Ach, Zoltan Timar, Joel Myerson, Jeffrey Robert Sampson, Holly Hogrefe
  • Patent number: 10240196
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: March 26, 2019
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen
  • Publication number: 20170342483
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Application
    Filed: May 27, 2016
    Publication date: November 30, 2017
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen
  • Patent number: 9783791
    Abstract: The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: October 10, 2017
    Assignee: Agilent Technologies, Inc.
    Inventors: Holly Hogrefe, Bahram Arezi, Weimei Xing
  • Patent number: 9523085
    Abstract: The present invention provides mutants of DNA polymerases having an increased rate of incorporation of nucleotides into nucleic acids undergoing polymerization and having an enhanced resistance to inhibitors of DNA polymerase activity. The mutant polymerases are well suited for fast PCR applications, for PCR amplification of targets in samples that contain inhibitors of wild-type polymerases, and for fast PCR amplification of samples containing DNA polymerase inhibitors. In exemplary embodiments, the mutants are mutants of Taq DNA polymerase.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: December 20, 2016
    Assignee: Agilent Technologies Inc.
    Inventors: Holly Hogrefe, Michelle Cayouette, Jeffrey Fox, Connie J. Hansen, Jennifer Lapira, Bahram Arezi, Nancy McKinney
  • Patent number: 9181534
    Abstract: The subject invention relates to compositions comprising an enzyme mixture which comprises a first enzyme and a second enzyme, where the first enzyme comprises a DNA polymerization activity and the second enzyme comprises an 5?-3? exonuclease activity and a reduced DNA polymerization activity. The invention also relates to the above compositions in kit format and methods for high fidelity DNA synthesis using the subject compositions of the invention.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: November 10, 2015
    Assignee: Agilent Technologies Inc.
    Inventors: Holly Hogrefe, Michael Borns, Joseph A. Sorge
  • Patent number: 9085762
    Abstract: The invention relates to compositions and methods utilizing split polymerase enzymes composed of at least two discrete polypeptides that stably associate to form a single polymerase. The invention further relates to nucleic acid constructs for expressing the split polymerases of the invention, and methods for using the split polymerases of the invention. The enzymes of the invention are useful in many applications calling for the detectable labeling of nucleic acids and are particularly useful in quantitative PCR (QPCR) and DNA sequencing applications.
    Type: Grant
    Filed: December 31, 2007
    Date of Patent: July 21, 2015
    Assignee: Agilent Technologies, Inc.
    Inventors: Holly Hogrefe, Lydia Wu, Jeffrey D. Fox, Connie Jo Hansen
  • Patent number: 8772006
    Abstract: The invention features a novel isolated Family B DNA polymerase, a Thermococcus polymerase JDF-3, and mutant recombinant forms thereof. Mutant polymerases of the invention are deficient in 3? to 5? exonuclease activity and/or exhibit reduced discrimination against non-conventional nucleotides relative to the wild-type form of the polymerase.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: July 8, 2014
    Assignee: Agilent Technologies, Inc.
    Inventors: Joseph A. Sorge, Connie Jo Hansen, Holly Hogrefe
  • Publication number: 20130323725
    Abstract: This disclosure provides a method comprising: a) clamping the top and bottom strands of a double stranded DNA molecule to produce a duplex in which the top and bottom strands are linked; b) denaturing the duplex to produce a denatured product; and c) renaturing the denatured product in the presence of a labeled oligonucleotide that is complementary to a sequence of nucleotides in the double stranded DNA molecule, thereby producing a D-loop-containing product. Kits for performing the method and products made by the method are also provided.
    Type: Application
    Filed: March 14, 2013
    Publication date: December 5, 2013
    Applicant: AGILENT TECHNOLOGIES, INC.
    Inventors: BRIAN JON PETER, ROBERT A. ACH, ZOLTAN TIMAR, JOEL MYERSON, JEFFREY ROBERT SAMPSON, HOLLY HOGREFE
  • Patent number: 8268605
    Abstract: The invention features a novel isolated Family B DNA polymerase, a Thermococcus polymerase JDF-3, and mutant recombinant forms thereof. Mutant polymerases of the invention are deficient in 3? to 5? exonuclease activity and/or exhibit reduced discrimination against non-conventional nucleotides relative to the wild-type form of the polymerase.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: September 18, 2012
    Assignee: Agilent Technologies, Inc.
    Inventors: Joseph A. Sorge, Connie Jo Hansen, Holly Hogrefe
  • Publication number: 20120003713
    Abstract: The invention provides novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases. Included within the aspects of the invention are methods for identifying compositions with a polymerase enhancing activity, methods for purifying and using these compositions, and specific extracts, proteins, and complexes that function to enhance polymerase activity. As an example, specifically described is nucleotide and amino acid sequence information for a Pyrococcus furiosus PEF (P45), which was used to produce a recombinant PEF.
    Type: Application
    Filed: March 18, 2011
    Publication date: January 5, 2012
    Applicant: AGILENT TECHNOLOGIES, INC.
    Inventors: Connie Hansen, Holly Hogrefe, Michael Borns, Michael Muhich
  • Patent number: 7943358
    Abstract: The invention provides novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases. Included within the aspects of the invention are methods for identifying compositions with a polymerase enhancing activity, methods for purifying and using these compositions, and specific extracts, proteins, and complexes that function to enhance polymerase activity. As an example, specifically described is nucleotide and amino acid sequence information for a Pyrococcus furiousus PEF (P45), which was used to produce a recombinant PEF.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: May 17, 2011
    Assignee: Agilent Technologies, Inc.
    Inventors: Connie J. Hansen, Holly Hogrefe, Michael Borns, Michael Muhich
  • Patent number: RE49207
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: September 13, 2022
    Assignee: Agilent Technologies, Inc.
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen